Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcinoma

NCT07152821 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

834

Enrollment

NETWORK

Sponsor class

Conditions

Colorectal Cancer

Interventions

OTHER: Best Supportive Care
DRUG: Balstilimab
DRUG: Botensilimab

Sponsor

Canadian Cancer Trials Group

Collaborators

[object Object]
[object Object]
[object Object]